Sustainability | November 01, 2024
Lupin to develop inhalers with near-zero global warming potential propellants
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
New inhalers would have near-zero Global Warming Potential propellant
The company does not expect this development to have any material impact on the current business operations
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
Agreement further expands Aptar Pharma’s leading respiratory portfolio
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Subscribe To Our Newsletter & Stay Updated
